ReviewCureus2026
Recurrent Urinary Tract Infections in Women: Current Management Guidelines and Therapeutic Options.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recurrent urinary tract infections (rUTIs) are a common clinical problem affecting women worldwide. These infections significantly impair the quality of life, impacting social and sexual relationships, self-esteem, and work productivity. The escalating global threat of antimicrobial resistance necessitates a shift from repetitive antibiotic use toward effective non-antimicrobial preventive strategies. The objective of this literature review is to summarize the latest diagnostic and management guidelines (2023-2026) for rUTI in women, with a particular focus on comparing recommendations from international (European Association of Urology, American Urological Association/Canadian Urological Association/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction) and Polish (Polish Urological Association, Polish Society of Gynecologists and Obstetricians, Polish Society of Family Medicine) scientific societies. A literature review was performed based on current guidelines and recent clinical studies. The literature selection involved databases such as PubMed/MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, and Google Scholar. This review summarizes current recommendations for the diagnosis, prevention, and management of rUTIs in women. Antibiotic and non-antibiotic preventive strategies are discussed, including vaginal estrogen, methenamine hippurate, immunoactive prophylaxis, D-mannose, and cranberry products. Differences and similarities between international and Polish guidelines are highlighted. Management of rUTI requires a personalized, stepwise approach prioritizing behavioral modifications and non-antibiotic interventions. Clinicians must balance treatment efficacy with antimicrobial stewardship to mitigate collateral damage to the host microbiome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.